Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study – The BMJ May 31, 2023
Experimental Decoy Protects Against SARS-CoV-2 Infection | NYU Langone News – NYU Langone Health May 30, 2023
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection – JAMA Network May 25, 2023
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo – Science May 24, 2023
Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection | Proceedings of the National Academy of Sciences – pnas.org May 23, 2023
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants – Nature.com May 16, 2023
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates – Science May 16, 2023
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant – Nature.com May 11, 2023
Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release – Science April 25, 2023